SlideShare a Scribd company logo
Discussion Forum on ICH Q7 & Q11
Scientific & Regulatory Perspectives
Dr. Obaid Ali
Deputy Director, DRAP
Member ISPE, PDA
23 April 2017 (Program A)
21 May 2017 (Program B)
ICH Q7 & Q11
Scientific & Regulatory Perspectives
Starting Material
Handling Site
Starting Material
Handling Site
Cyanide compound also
handled there
Starting Material
Handling Site
Cyanide compound also
handled there
Risk of
Contamination
was not
discussed
Starting Material
Handling Site
Cyanide compound also
handled there
Risk of
Contamination
was not
discussed
What will be
your
judgment?
Outline of the Talk
1. GMP Compliance
 Background
 Starting Materials
 Change Control
2. Common GMP Deficiencies reported
Why API production should
comply with GMP?
Review of
some
concepts of
GMP for
APIs
Observed
trends &
deficiencies
during API
inspections
Why GMP in API production?
Ensuring the quality of the API greatly
contributes to achieving the objective of
building the quality, safety and efficacy into
the product.
Risk based approach in Inspection
(Parameters)
Polymorphism
Solubility in
water
Complexity of
route of Synthesis
Solvents used
Impurities –
genotoxic
Sterile API
Fermentation
Toxicity, Activity,
Potency
Particle size
Site compliance
information
Other properties to be
considered
GMP for APIs (ICH Q7): Starting Materials
From what point does GMP for APIs start to be applied ?
– For synthetic process, this corresponds to the
introduction of the API starting material into the
process;
– Stringency of GMP in API manufacturing increases
from early steps to final steps
GMP for APIs (ICH Q7): Starting Materials
Advanced intermediates and crude APIs outsourced should
be manufactured in compliance with GMP
– “late intermediate and crude API” manufacturers should
be considered as contract manufacturers
(WHO GMP for APIs chapter 16 applicable)
GMP for APIs (ICH Q7): Starting Materials
Sterilization and aseptic processing should be
performed according to GMP related to Sterile
pharmaceutical products.
APIs
Registered
Intermediates
Critical Raw
Materials
Non critical
Raw Materials
Quantity of
materials in each
category is likely
to decrease as the
criticality increases
as indicated in the
above triangle
GMP for APIs (Change Control)
RM, specifications, analytical methods, facilities,
support systems, equipment (including
computerized systems), processing steps,
labelling and packaging materials
That can impact the quality of the API
Proposal drafted, reviewed and approved
by the appropriate organisational unit
Change reviewed and approved by QU
Classification and impact assessment
Evaluation and monitoring Notification
Facilities, Equipment and Utilities System
Critical operation
with prolonged
exposure to the
environment
Non critical operation
with prolonged
exposure to the
environment
Non critical or
critical operation in a
closed equipment
Prevent mix-
ups
Precautions
implemented
Cleaning
methodology
& intervals
Contamination
Risk
assessment
(HVAC)
To prevent
build-up and
carry-over of
contaminants
(degradants)
Supplier Qualification for API Manufacturers
API manufacturer should have
supplier qualification
procedures in place for their
suppliers of critical and non-
critical raw materials, API
Starting Materials, Registered
Intermediates and APIs
(in the case of contract
manufacturers)
an evaluation that provides
adequate evidence that the
manufacturer can
consistently provide
material meeting
specifications
At least
identity testing
of each batch
Reduced testing for
approved/validated suppliers
Past quality
history
Full analysis at
least on three
batches before
starting reduced-
testing
Reliability of the
CoA checked at
regular intervals:
a full analysis and
compared with
the certificates of
analysis
Precaution for bulk
deliveries in non-
dedicated tankers.
Certificate of cleaning,
testing for trace
impurities, supplier audit.
Blending Operations: only
batches meeting established
specifications
• Blending Operations
– Expiry or retest date of the
blended batch based on the
manufacturing date of the
oldest batch included.
– Should be controlled and
documented – traceability
1. Blending small
batches to ↑se batch size
2. Blending tailings
• Blending Operations
– Validation for homogeneity
following blending
APIs for OSDs/Suspensions
1. Particle size distribution
2. Bulk density
3. Tap density
Rejection & Re-use of Materials
Re-process
Rework
Back into the process
Reprocessing by
repeating any step
(crystallization)
Physical or Chemical
Manipulation steps
(Filtration, chromatography,
distillation)
R
E
P
R
O
C
E
S
S
Such reprocessing is not
allowed in majority of the
batches
If so add in Standard Mfg Process
Continuation of a process
step after an in-process
control test has shown
that the step is
incomplete.
R
E
P
R
O
C
E
S
S
It is considered a
normal process,
not re-processing
Repeating a chemical reaction
and
Introducing untreated material
back into process is re-
processing
However, if it is part of
established process, it is ok
R
E
P
R
O
C
E
S
S
Be careful of
potential
formation of by-
products & over
reacted materials
Investigation & reason
of non-conformance
before going for
rework
R
E
W
O
R
K
I
N
G
Careful evaluation, testing
& stability testing,
additional testing
Prove equivalent quality with the
original process
• Recovery of Materials and solvents
– Reactants, intermediates or APIs may
be recovered from mother liquor or
filtrates.
– Must use approved procedures and
specifications.
– Recovered solvents may be reused in
same process or in different process if
confirmed to meet appropriate
standards.
– Fresh and recovered solvents and
reagents can be combined if confirmed
their adequacy
1. Approved procedures
2. Suitable specs
3. Adequate testing
5. Use documented
1. No approved procedures
2. Specs – carry over
impurities
3. Not adequately tested
4. Use not documented
Very careful while
reprocessing or reworking or
even destroying
R
E
T
U
R
N
Document
Document &
Document
Common GMP deficiencies reported
API manufacturers
• Inadequate vendor audit and approval:
– A contractor audit established that the cleaning procedures were
inadequate and the deficiency was classified as critical. As
compliance mechanism, it was decided that the API
manufacturer shall supply organic solvents for cleaning,
however, the solvents were not identified and criteria for their
selected was not high lighted given that the report did not list
the other materials handled on the site.
• Inadequate vendor audit and approval:
– The suppliers of key starting materials had not been evaluated
to establish their quality system with respect to the handling of
respective material.
• Furthermore, these materials were accepted based on the
sole supplier's certificate of analysis and there was no
system in place to periodically and independently evaluate
the accuracy of these certificates.
• Inadequate control of API starting material (API-SM):
– Block A, where the API-SM was manufactured, was
unacceptable in that,
• Standards of maintenance and house-keeping were unacceptable
including the fabrication of building
– There were many examples of leaks in pipework and process equipment
– The equipment used was unacceptable, both in design and standards of housekeeping
and maintenance.
– No utility or process pipework were labelled
– No QC testing was done on API-SM.
– Specifications for API-SM were due for review July 2010 but
this was never conducted.
• Inadequate sampling and storage of materials
– The number of drums sampled for a consignment of 340 drums
of ABC B. No. 123 as recorded on the sampling sheet (5) was
less than that required by the sampling procedure (√N+1 = 19).
– ABC BN 123 was stored in an uncontrolled T° storage area
(same warehouse where staff bus was parked). The
recommended storage condition for this material is below 150C
– API XYZ B. No. 1111 had a release status label dated
09.02.2008 although its manufacturing date was 10.02.2008
ICH Q7 & Q11

More Related Content

What's hot

quality assurance audits
quality assurance audits quality assurance audits
quality assurance audits
rasikawalunj
 
ICHQ7 & Q11 (3 of 7)
ICHQ7 & Q11 (3 of 7) ICHQ7 & Q11 (3 of 7)
ICHQ7 & Q11 (3 of 7)
Hubdar Ali
 
ICHQ7 & Q11 (5 of 7)
ICHQ7 & Q11 (5 of 7) ICHQ7 & Q11 (5 of 7)
ICHQ7 & Q11 (5 of 7)
Hubdar Ali
 
Gmp compliance
Gmp complianceGmp compliance
Gmp compliance
Gaurav Kr
 
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụngTiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Product development Global prospective
Product development   Global prospective Product development   Global prospective
Product development Global prospective
Guru Balaji .S
 
Key factors and main change over in iso 17025 2017
Key factors and main change over in  iso 17025 2017Key factors and main change over in  iso 17025 2017
Key factors and main change over in iso 17025 2017
Dr.Lenin raja
 
Gmp (q7 ich guide) & Stem cells-based therapy product manufacturing
Gmp (q7 ich guide) & Stem cells-based therapy product manufacturingGmp (q7 ich guide) & Stem cells-based therapy product manufacturing
Gmp (q7 ich guide) & Stem cells-based therapy product manufacturing
M. Agung Sumantri
 
ICH 7- GMP Guidance for API-questions & answers
ICH 7- GMP Guidance for API-questions & answersICH 7- GMP Guidance for API-questions & answers
ICH 7- GMP Guidance for API-questions & answers
MD. SELIM REZA
 
Vish GMP Presentation
Vish GMP PresentationVish GMP Presentation
Vish GMP Presentation
Vishal Parikh
 
WHO GMP Requirements
WHO GMP  RequirementsWHO GMP  Requirements
WHO GMP Requirements
Deekshitha HS
 
GxP and cGxP in Bio/Pharmaceutical Industry
GxP and cGxP in Bio/Pharmaceutical IndustryGxP and cGxP in Bio/Pharmaceutical Industry
GxP and cGxP in Bio/Pharmaceutical Industry
Prof. Dr. Basavaraj Nanjwade
 
Validation master plan
Validation master planValidation master plan
Validation master plan
Priyanka Kandhare
 
Pharmaceutical Quality System
Pharmaceutical Quality System Pharmaceutical Quality System
Pharmaceutical Quality System
GMP EDUCATION : Not for Profit Organization
 
ISO/IEC 17025:2017 Required documentation
ISO/IEC 17025:2017 Required documentationISO/IEC 17025:2017 Required documentation
ISO/IEC 17025:2017 Required documentation
Mohamed Salama Elimam
 

What's hot (17)

quality assurance audits
quality assurance audits quality assurance audits
quality assurance audits
 
ICHQ7 & Q11 (3 of 7)
ICHQ7 & Q11 (3 of 7) ICHQ7 & Q11 (3 of 7)
ICHQ7 & Q11 (3 of 7)
 
ICHQ7 & Q11 (5 of 7)
ICHQ7 & Q11 (5 of 7) ICHQ7 & Q11 (5 of 7)
ICHQ7 & Q11 (5 of 7)
 
Gmp compliance
Gmp complianceGmp compliance
Gmp compliance
 
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụngTiêu chuẩn GMP WHO cho các hoạt chất dược dụng
Tiêu chuẩn GMP WHO cho các hoạt chất dược dụng
 
Product development Global prospective
Product development   Global prospective Product development   Global prospective
Product development Global prospective
 
Key factors and main change over in iso 17025 2017
Key factors and main change over in  iso 17025 2017Key factors and main change over in  iso 17025 2017
Key factors and main change over in iso 17025 2017
 
Qa in ba be
Qa in ba beQa in ba be
Qa in ba be
 
Gmp (q7 ich guide) & Stem cells-based therapy product manufacturing
Gmp (q7 ich guide) & Stem cells-based therapy product manufacturingGmp (q7 ich guide) & Stem cells-based therapy product manufacturing
Gmp (q7 ich guide) & Stem cells-based therapy product manufacturing
 
ICH 7- GMP Guidance for API-questions & answers
ICH 7- GMP Guidance for API-questions & answersICH 7- GMP Guidance for API-questions & answers
ICH 7- GMP Guidance for API-questions & answers
 
Vish GMP Presentation
Vish GMP PresentationVish GMP Presentation
Vish GMP Presentation
 
WHO GMP Requirements
WHO GMP  RequirementsWHO GMP  Requirements
WHO GMP Requirements
 
Excipient Auditing
Excipient AuditingExcipient Auditing
Excipient Auditing
 
GxP and cGxP in Bio/Pharmaceutical Industry
GxP and cGxP in Bio/Pharmaceutical IndustryGxP and cGxP in Bio/Pharmaceutical Industry
GxP and cGxP in Bio/Pharmaceutical Industry
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
Pharmaceutical Quality System
Pharmaceutical Quality System Pharmaceutical Quality System
Pharmaceutical Quality System
 
ISO/IEC 17025:2017 Required documentation
ISO/IEC 17025:2017 Required documentationISO/IEC 17025:2017 Required documentation
ISO/IEC 17025:2017 Required documentation
 

Similar to ICH Q7 & Q11

Quality system gmp
Quality system gmpQuality system gmp
Quality system gmp
aveekdatta7
 
GMP- APQR Training
GMP- APQR TrainingGMP- APQR Training
GMP- APQR Training
Dr. Amsavel A
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
amol dighe
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
amol dighe
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. Amsavel
Dr. Amsavel A
 
Validation Theory And Application 3
Validation   Theory And Application 3Validation   Theory And Application 3
Validation Theory And Application 3antoi alvarez
 
Good Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality ControlGood Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality Control
Dr Rajendra Patel
 
Facility & Equipment Quality System Outline
Facility & Equipment Quality System OutlineFacility & Equipment Quality System Outline
Facility & Equipment Quality System Outline
Joseph Busfield
 
Technology transfer from Research and development to production
Technology transfer from Research and development  to productionTechnology transfer from Research and development  to production
Technology transfer from Research and development to production
Archana Mandava
 
Quality System Expectations : Single-Use Materials
Quality System Expectations : Single-Use MaterialsQuality System Expectations : Single-Use Materials
Quality System Expectations : Single-Use Materials
gueste42f6b5
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & Validation
Pharmaceutical
 
Contamination Control Cleaning Validation.pdf
Contamination Control Cleaning Validation.pdfContamination Control Cleaning Validation.pdf
Contamination Control Cleaning Validation.pdf
HassanHani5
 
Face.ppt
Face.pptFace.ppt
Latest trends in manufacturing quality
Latest trends in manufacturing qualityLatest trends in manufacturing quality
Latest trends in manufacturing quality
TGA Australia
 
GMP- APQR training
GMP- APQR  trainingGMP- APQR  training
GMP- APQR training
Amsavel Vel
 
Ich Q7A Guidelines
Ich Q7A GuidelinesIch Q7A Guidelines
Ich Q7A Guidelines
Manali Parab
 
Pilot plant scaleup.pptx
Pilot plant scaleup.pptxPilot plant scaleup.pptx
Pilot plant scaleup.pptx
ANANDGADAD2
 
Q7 introduction quality managment
Q7 introduction  quality managmentQ7 introduction  quality managment
Q7 introduction quality managment
Sucheta Gaikwad
 
Pilot plant scaleuptechnique
Pilot plant scaleuptechniquePilot plant scaleuptechnique
Pilot plant scaleuptechniquejiten patel
 

Similar to ICH Q7 & Q11 (20)

Quality system gmp
Quality system gmpQuality system gmp
Quality system gmp
 
GMP- APQR Training
GMP- APQR TrainingGMP- APQR Training
GMP- APQR Training
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. Amsavel
 
Validation Theory And Application 3
Validation   Theory And Application 3Validation   Theory And Application 3
Validation Theory And Application 3
 
Good Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality ControlGood Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality Control
 
Facility & Equipment Quality System Outline
Facility & Equipment Quality System OutlineFacility & Equipment Quality System Outline
Facility & Equipment Quality System Outline
 
Technology transfer from Research and development to production
Technology transfer from Research and development  to productionTechnology transfer from Research and development  to production
Technology transfer from Research and development to production
 
Quality System Expectations : Single-Use Materials
Quality System Expectations : Single-Use MaterialsQuality System Expectations : Single-Use Materials
Quality System Expectations : Single-Use Materials
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & Validation
 
Contamination Control Cleaning Validation.pdf
Contamination Control Cleaning Validation.pdfContamination Control Cleaning Validation.pdf
Contamination Control Cleaning Validation.pdf
 
Face.ppt
Face.pptFace.ppt
Face.ppt
 
GMP quality assurance
GMP quality assuranceGMP quality assurance
GMP quality assurance
 
Latest trends in manufacturing quality
Latest trends in manufacturing qualityLatest trends in manufacturing quality
Latest trends in manufacturing quality
 
GMP- APQR training
GMP- APQR  trainingGMP- APQR  training
GMP- APQR training
 
Ich Q7A Guidelines
Ich Q7A GuidelinesIch Q7A Guidelines
Ich Q7A Guidelines
 
Pilot plant scaleup.pptx
Pilot plant scaleup.pptxPilot plant scaleup.pptx
Pilot plant scaleup.pptx
 
Q7 introduction quality managment
Q7 introduction  quality managmentQ7 introduction  quality managment
Q7 introduction quality managment
 
Pilot plant scaleuptechnique
Pilot plant scaleuptechniquePilot plant scaleuptechnique
Pilot plant scaleuptechnique
 

More from Obaid Ali / Roohi B. Obaid

A Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological ProductsA Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological Products
Obaid Ali / Roohi B. Obaid
 
Centre for Quality Sciences-Information File-2024.pdf
Centre for Quality Sciences-Information File-2024.pdfCentre for Quality Sciences-Information File-2024.pdf
Centre for Quality Sciences-Information File-2024.pdf
Obaid Ali / Roohi B. Obaid
 
A Tragic Resistance to Learn.pdf
A Tragic Resistance to Learn.pdfA Tragic Resistance to Learn.pdf
A Tragic Resistance to Learn.pdf
Obaid Ali / Roohi B. Obaid
 
230930.pdf
230930.pdf230930.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdfDemonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
Obaid Ali / Roohi B. Obaid
 
Centre for Quality Sciences-2023
Centre for Quality Sciences-2023Centre for Quality Sciences-2023
Centre for Quality Sciences-2023
Obaid Ali / Roohi B. Obaid
 
Track, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdfTrack, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdf
Obaid Ali / Roohi B. Obaid
 
Confidence on Generics.pdf
Confidence on Generics.pdfConfidence on Generics.pdf
Confidence on Generics.pdf
Obaid Ali / Roohi B. Obaid
 
Neurotoxicity & Neurodegenaration.pdf
Neurotoxicity & Neurodegenaration.pdfNeurotoxicity & Neurodegenaration.pdf
Neurotoxicity & Neurodegenaration.pdf
Obaid Ali / Roohi B. Obaid
 
Application of Data & AI in Pharma 4
Application of Data & AI in Pharma 4Application of Data & AI in Pharma 4
Application of Data & AI in Pharma 4
Obaid Ali / Roohi B. Obaid
 
PICS-ICH
PICS-ICHPICS-ICH
Quality Affairs of Pharmaceuticals
Quality Affairs of PharmaceuticalsQuality Affairs of Pharmaceuticals
Quality Affairs of Pharmaceuticals
Obaid Ali / Roohi B. Obaid
 
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
Obaid Ali / Roohi B. Obaid
 
CQS Session - RO - 16 Oct 2022.pdf
CQS Session - RO - 16 Oct 2022.pdfCQS Session - RO - 16 Oct 2022.pdf
CQS Session - RO - 16 Oct 2022.pdf
Obaid Ali / Roohi B. Obaid
 
GMP Session for Professional Development.pdf
GMP Session for Professional Development.pdfGMP Session for Professional Development.pdf
GMP Session for Professional Development.pdf
Obaid Ali / Roohi B. Obaid
 
Q & A - June - Sep 2022.pdf
Q & A - June - Sep 2022.pdfQ & A - June - Sep 2022.pdf
Q & A - June - Sep 2022.pdf
Obaid Ali / Roohi B. Obaid
 
Judging Science & Prior Knowledge Beyond the Line
Judging Science & Prior Knowledge Beyond the LineJudging Science & Prior Knowledge Beyond the Line
Judging Science & Prior Knowledge Beyond the Line
Obaid Ali / Roohi B. Obaid
 
Maturing Drug Quality to Deliver Promise
Maturing Drug Quality to Deliver PromiseMaturing Drug Quality to Deliver Promise
Maturing Drug Quality to Deliver Promise
Obaid Ali / Roohi B. Obaid
 
PQRS 2022 - Education
PQRS  2022 - EducationPQRS  2022 - Education
PQRS 2022 - Education
Obaid Ali / Roohi B. Obaid
 
4 - GMP June 2022 - CQS.pdf
4 - GMP June 2022 - CQS.pdf4 - GMP June 2022 - CQS.pdf
4 - GMP June 2022 - CQS.pdf
Obaid Ali / Roohi B. Obaid
 

More from Obaid Ali / Roohi B. Obaid (20)

A Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological ProductsA Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological Products
 
Centre for Quality Sciences-Information File-2024.pdf
Centre for Quality Sciences-Information File-2024.pdfCentre for Quality Sciences-Information File-2024.pdf
Centre for Quality Sciences-Information File-2024.pdf
 
A Tragic Resistance to Learn.pdf
A Tragic Resistance to Learn.pdfA Tragic Resistance to Learn.pdf
A Tragic Resistance to Learn.pdf
 
230930.pdf
230930.pdf230930.pdf
230930.pdf
 
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdfDemonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
 
Centre for Quality Sciences-2023
Centre for Quality Sciences-2023Centre for Quality Sciences-2023
Centre for Quality Sciences-2023
 
Track, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdfTrack, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdf
 
Confidence on Generics.pdf
Confidence on Generics.pdfConfidence on Generics.pdf
Confidence on Generics.pdf
 
Neurotoxicity & Neurodegenaration.pdf
Neurotoxicity & Neurodegenaration.pdfNeurotoxicity & Neurodegenaration.pdf
Neurotoxicity & Neurodegenaration.pdf
 
Application of Data & AI in Pharma 4
Application of Data & AI in Pharma 4Application of Data & AI in Pharma 4
Application of Data & AI in Pharma 4
 
PICS-ICH
PICS-ICHPICS-ICH
PICS-ICH
 
Quality Affairs of Pharmaceuticals
Quality Affairs of PharmaceuticalsQuality Affairs of Pharmaceuticals
Quality Affairs of Pharmaceuticals
 
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
 
CQS Session - RO - 16 Oct 2022.pdf
CQS Session - RO - 16 Oct 2022.pdfCQS Session - RO - 16 Oct 2022.pdf
CQS Session - RO - 16 Oct 2022.pdf
 
GMP Session for Professional Development.pdf
GMP Session for Professional Development.pdfGMP Session for Professional Development.pdf
GMP Session for Professional Development.pdf
 
Q & A - June - Sep 2022.pdf
Q & A - June - Sep 2022.pdfQ & A - June - Sep 2022.pdf
Q & A - June - Sep 2022.pdf
 
Judging Science & Prior Knowledge Beyond the Line
Judging Science & Prior Knowledge Beyond the LineJudging Science & Prior Knowledge Beyond the Line
Judging Science & Prior Knowledge Beyond the Line
 
Maturing Drug Quality to Deliver Promise
Maturing Drug Quality to Deliver PromiseMaturing Drug Quality to Deliver Promise
Maturing Drug Quality to Deliver Promise
 
PQRS 2022 - Education
PQRS  2022 - EducationPQRS  2022 - Education
PQRS 2022 - Education
 
4 - GMP June 2022 - CQS.pdf
4 - GMP June 2022 - CQS.pdf4 - GMP June 2022 - CQS.pdf
4 - GMP June 2022 - CQS.pdf
 

Recently uploaded

Public Speaking Tips to Help You Be A Strong Leader.pdf
Public Speaking Tips to Help You Be A Strong Leader.pdfPublic Speaking Tips to Help You Be A Strong Leader.pdf
Public Speaking Tips to Help You Be A Strong Leader.pdf
Pinta Partners
 
一比一原版杜克大学毕业证(Duke毕业证)成绩单留信认证
一比一原版杜克大学毕业证(Duke毕业证)成绩单留信认证一比一原版杜克大学毕业证(Duke毕业证)成绩单留信认证
一比一原版杜克大学毕业证(Duke毕业证)成绩单留信认证
gcljeuzdu
 
原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样
原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样
原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样
tdt5v4b
 
Leadership Ethics and Change, Purpose to Impact Plan
Leadership Ethics and Change, Purpose to Impact PlanLeadership Ethics and Change, Purpose to Impact Plan
Leadership Ethics and Change, Purpose to Impact Plan
Muhammad Adil Jamil
 
Strategic Org Design with Org Topologies™
Strategic Org Design with Org Topologies™Strategic Org Design with Org Topologies™
Strategic Org Design with Org Topologies™
Alexey Krivitsky
 
Risk-Management-presentation for cooperatives
Risk-Management-presentation for cooperativesRisk-Management-presentation for cooperatives
Risk-Management-presentation for cooperatives
bernanbumatay1
 
原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样
原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样
原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样
tdt5v4b
 
The Management Guide: From Projects to Portfolio
The Management Guide: From Projects to PortfolioThe Management Guide: From Projects to Portfolio
The Management Guide: From Projects to Portfolio
Ahmed AbdelMoneim
 
在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样
在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样
在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样
tdt5v4b
 
Case Analysis - The Sky is the Limit | Principles of Management
Case Analysis - The Sky is the Limit | Principles of ManagementCase Analysis - The Sky is the Limit | Principles of Management
Case Analysis - The Sky is the Limit | Principles of Management
A. F. M. Rubayat-Ul Jannat
 
Comparing Stability and Sustainability in Agile Systems
Comparing Stability and Sustainability in Agile SystemsComparing Stability and Sustainability in Agile Systems
Comparing Stability and Sustainability in Agile Systems
Rob Healy
 
20240608 QFM019 Engineering Leadership Reading List May 2024
20240608 QFM019 Engineering Leadership Reading List May 202420240608 QFM019 Engineering Leadership Reading List May 2024
20240608 QFM019 Engineering Leadership Reading List May 2024
Matthew Sinclair
 
Senior Project and Engineering Leader Jim Smith.pdf
Senior Project and Engineering Leader Jim Smith.pdfSenior Project and Engineering Leader Jim Smith.pdf
Senior Project and Engineering Leader Jim Smith.pdf
Jim Smith
 
在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样
在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样
在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样
tdt5v4b
 
Integrity in leadership builds trust by ensuring consistency between words an...
Integrity in leadership builds trust by ensuring consistency between words an...Integrity in leadership builds trust by ensuring consistency between words an...
Integrity in leadership builds trust by ensuring consistency between words an...
Ram V Chary
 
Employment Practices Regulation and Multinational Corporations
Employment PracticesRegulation and Multinational CorporationsEmployment PracticesRegulation and Multinational Corporations
Employment Practices Regulation and Multinational Corporations
RoopaTemkar
 
Enriching engagement with ethical review processes
Enriching engagement with ethical review processesEnriching engagement with ethical review processes
Enriching engagement with ethical review processes
strikingabalance
 
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
William (Bill) H. Bender, FCSI
 
CV Ensio Suopanki1.pdf ENGLISH Russian Finnish German
CV Ensio Suopanki1.pdf ENGLISH Russian Finnish GermanCV Ensio Suopanki1.pdf ENGLISH Russian Finnish German
CV Ensio Suopanki1.pdf ENGLISH Russian Finnish German
EUS+ Management & Consulting Excellence
 

Recently uploaded (19)

Public Speaking Tips to Help You Be A Strong Leader.pdf
Public Speaking Tips to Help You Be A Strong Leader.pdfPublic Speaking Tips to Help You Be A Strong Leader.pdf
Public Speaking Tips to Help You Be A Strong Leader.pdf
 
一比一原版杜克大学毕业证(Duke毕业证)成绩单留信认证
一比一原版杜克大学毕业证(Duke毕业证)成绩单留信认证一比一原版杜克大学毕业证(Duke毕业证)成绩单留信认证
一比一原版杜克大学毕业证(Duke毕业证)成绩单留信认证
 
原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样
原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样
原版制作(澳洲WSU毕业证书)西悉尼大学毕业证文凭证书一模一样
 
Leadership Ethics and Change, Purpose to Impact Plan
Leadership Ethics and Change, Purpose to Impact PlanLeadership Ethics and Change, Purpose to Impact Plan
Leadership Ethics and Change, Purpose to Impact Plan
 
Strategic Org Design with Org Topologies™
Strategic Org Design with Org Topologies™Strategic Org Design with Org Topologies™
Strategic Org Design with Org Topologies™
 
Risk-Management-presentation for cooperatives
Risk-Management-presentation for cooperativesRisk-Management-presentation for cooperatives
Risk-Management-presentation for cooperatives
 
原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样
原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样
原版制作(CDU毕业证书)查尔斯达尔文大学毕业证PDF成绩单一模一样
 
The Management Guide: From Projects to Portfolio
The Management Guide: From Projects to PortfolioThe Management Guide: From Projects to Portfolio
The Management Guide: From Projects to Portfolio
 
在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样
在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样
在线办理(UVic毕业证书)维多利亚大学毕业证录取通知书一模一样
 
Case Analysis - The Sky is the Limit | Principles of Management
Case Analysis - The Sky is the Limit | Principles of ManagementCase Analysis - The Sky is the Limit | Principles of Management
Case Analysis - The Sky is the Limit | Principles of Management
 
Comparing Stability and Sustainability in Agile Systems
Comparing Stability and Sustainability in Agile SystemsComparing Stability and Sustainability in Agile Systems
Comparing Stability and Sustainability in Agile Systems
 
20240608 QFM019 Engineering Leadership Reading List May 2024
20240608 QFM019 Engineering Leadership Reading List May 202420240608 QFM019 Engineering Leadership Reading List May 2024
20240608 QFM019 Engineering Leadership Reading List May 2024
 
Senior Project and Engineering Leader Jim Smith.pdf
Senior Project and Engineering Leader Jim Smith.pdfSenior Project and Engineering Leader Jim Smith.pdf
Senior Project and Engineering Leader Jim Smith.pdf
 
在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样
在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样
在线办理(Murdoch毕业证书)莫道克大学毕业证电子版成绩单一模一样
 
Integrity in leadership builds trust by ensuring consistency between words an...
Integrity in leadership builds trust by ensuring consistency between words an...Integrity in leadership builds trust by ensuring consistency between words an...
Integrity in leadership builds trust by ensuring consistency between words an...
 
Employment Practices Regulation and Multinational Corporations
Employment PracticesRegulation and Multinational CorporationsEmployment PracticesRegulation and Multinational Corporations
Employment Practices Regulation and Multinational Corporations
 
Enriching engagement with ethical review processes
Enriching engagement with ethical review processesEnriching engagement with ethical review processes
Enriching engagement with ethical review processes
 
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
W.H.Bender Quote 66 - ServPoints Sequence of Service™ should be Identified fo...
 
CV Ensio Suopanki1.pdf ENGLISH Russian Finnish German
CV Ensio Suopanki1.pdf ENGLISH Russian Finnish GermanCV Ensio Suopanki1.pdf ENGLISH Russian Finnish German
CV Ensio Suopanki1.pdf ENGLISH Russian Finnish German
 

ICH Q7 & Q11

  • 1. Discussion Forum on ICH Q7 & Q11 Scientific & Regulatory Perspectives Dr. Obaid Ali Deputy Director, DRAP Member ISPE, PDA 23 April 2017 (Program A) 21 May 2017 (Program B)
  • 2. ICH Q7 & Q11 Scientific & Regulatory Perspectives
  • 4. Starting Material Handling Site Cyanide compound also handled there
  • 5. Starting Material Handling Site Cyanide compound also handled there Risk of Contamination was not discussed
  • 6. Starting Material Handling Site Cyanide compound also handled there Risk of Contamination was not discussed What will be your judgment?
  • 7. Outline of the Talk 1. GMP Compliance  Background  Starting Materials  Change Control 2. Common GMP Deficiencies reported
  • 8. Why API production should comply with GMP? Review of some concepts of GMP for APIs Observed trends & deficiencies during API inspections
  • 9. Why GMP in API production? Ensuring the quality of the API greatly contributes to achieving the objective of building the quality, safety and efficacy into the product.
  • 10. Risk based approach in Inspection (Parameters) Polymorphism Solubility in water Complexity of route of Synthesis Solvents used Impurities – genotoxic Sterile API Fermentation Toxicity, Activity, Potency Particle size Site compliance information Other properties to be considered
  • 11. GMP for APIs (ICH Q7): Starting Materials From what point does GMP for APIs start to be applied ? – For synthetic process, this corresponds to the introduction of the API starting material into the process; – Stringency of GMP in API manufacturing increases from early steps to final steps
  • 12. GMP for APIs (ICH Q7): Starting Materials Advanced intermediates and crude APIs outsourced should be manufactured in compliance with GMP – “late intermediate and crude API” manufacturers should be considered as contract manufacturers (WHO GMP for APIs chapter 16 applicable)
  • 13. GMP for APIs (ICH Q7): Starting Materials Sterilization and aseptic processing should be performed according to GMP related to Sterile pharmaceutical products.
  • 14. APIs Registered Intermediates Critical Raw Materials Non critical Raw Materials Quantity of materials in each category is likely to decrease as the criticality increases as indicated in the above triangle
  • 15. GMP for APIs (Change Control)
  • 16. RM, specifications, analytical methods, facilities, support systems, equipment (including computerized systems), processing steps, labelling and packaging materials That can impact the quality of the API Proposal drafted, reviewed and approved by the appropriate organisational unit
  • 17. Change reviewed and approved by QU Classification and impact assessment Evaluation and monitoring Notification
  • 18. Facilities, Equipment and Utilities System
  • 19. Critical operation with prolonged exposure to the environment Non critical operation with prolonged exposure to the environment Non critical or critical operation in a closed equipment Prevent mix- ups Precautions implemented Cleaning methodology & intervals Contamination Risk assessment (HVAC) To prevent build-up and carry-over of contaminants (degradants)
  • 20. Supplier Qualification for API Manufacturers
  • 21. API manufacturer should have supplier qualification procedures in place for their suppliers of critical and non- critical raw materials, API Starting Materials, Registered Intermediates and APIs (in the case of contract manufacturers) an evaluation that provides adequate evidence that the manufacturer can consistently provide material meeting specifications At least identity testing of each batch
  • 22. Reduced testing for approved/validated suppliers Past quality history Full analysis at least on three batches before starting reduced- testing Reliability of the CoA checked at regular intervals: a full analysis and compared with the certificates of analysis
  • 23. Precaution for bulk deliveries in non- dedicated tankers. Certificate of cleaning, testing for trace impurities, supplier audit.
  • 24. Blending Operations: only batches meeting established specifications
  • 25. • Blending Operations – Expiry or retest date of the blended batch based on the manufacturing date of the oldest batch included. – Should be controlled and documented – traceability 1. Blending small batches to ↑se batch size 2. Blending tailings
  • 26. • Blending Operations – Validation for homogeneity following blending APIs for OSDs/Suspensions 1. Particle size distribution 2. Bulk density 3. Tap density
  • 27. Rejection & Re-use of Materials
  • 29. Back into the process Reprocessing by repeating any step (crystallization) Physical or Chemical Manipulation steps (Filtration, chromatography, distillation) R E P R O C E S S Such reprocessing is not allowed in majority of the batches If so add in Standard Mfg Process
  • 30. Continuation of a process step after an in-process control test has shown that the step is incomplete. R E P R O C E S S It is considered a normal process, not re-processing
  • 31. Repeating a chemical reaction and Introducing untreated material back into process is re- processing However, if it is part of established process, it is ok R E P R O C E S S Be careful of potential formation of by- products & over reacted materials
  • 32. Investigation & reason of non-conformance before going for rework R E W O R K I N G Careful evaluation, testing & stability testing, additional testing Prove equivalent quality with the original process
  • 33. • Recovery of Materials and solvents – Reactants, intermediates or APIs may be recovered from mother liquor or filtrates. – Must use approved procedures and specifications. – Recovered solvents may be reused in same process or in different process if confirmed to meet appropriate standards. – Fresh and recovered solvents and reagents can be combined if confirmed their adequacy 1. Approved procedures 2. Suitable specs 3. Adequate testing 5. Use documented 1. No approved procedures 2. Specs – carry over impurities 3. Not adequately tested 4. Use not documented
  • 34. Very careful while reprocessing or reworking or even destroying R E T U R N Document Document & Document
  • 35. Common GMP deficiencies reported API manufacturers
  • 36. • Inadequate vendor audit and approval: – A contractor audit established that the cleaning procedures were inadequate and the deficiency was classified as critical. As compliance mechanism, it was decided that the API manufacturer shall supply organic solvents for cleaning, however, the solvents were not identified and criteria for their selected was not high lighted given that the report did not list the other materials handled on the site.
  • 37. • Inadequate vendor audit and approval: – The suppliers of key starting materials had not been evaluated to establish their quality system with respect to the handling of respective material. • Furthermore, these materials were accepted based on the sole supplier's certificate of analysis and there was no system in place to periodically and independently evaluate the accuracy of these certificates.
  • 38. • Inadequate control of API starting material (API-SM): – Block A, where the API-SM was manufactured, was unacceptable in that, • Standards of maintenance and house-keeping were unacceptable including the fabrication of building – There were many examples of leaks in pipework and process equipment – The equipment used was unacceptable, both in design and standards of housekeeping and maintenance. – No utility or process pipework were labelled – No QC testing was done on API-SM. – Specifications for API-SM were due for review July 2010 but this was never conducted.
  • 39. • Inadequate sampling and storage of materials – The number of drums sampled for a consignment of 340 drums of ABC B. No. 123 as recorded on the sampling sheet (5) was less than that required by the sampling procedure (√N+1 = 19). – ABC BN 123 was stored in an uncontrolled T° storage area (same warehouse where staff bus was parked). The recommended storage condition for this material is below 150C – API XYZ B. No. 1111 had a release status label dated 09.02.2008 although its manufacturing date was 10.02.2008